What is MLTX stock price today?

MLTX (Moonlake Immunotherapeutics) stock is trading at $16.33 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MLTX stock going up or down today?

MLTX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MLTX stock now?

The decision to buy MLTX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MLTX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MLTX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MLTX stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MLTX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MLTX's P/E ratio?

P/E ratio data for MLTX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MLTX's market cap?

MLTX (Moonlake Immunotherapeutics) has a market capitalization of $1.16 billion, making it a small-cap stock.

What is MLTX's price to book ratio?

MLTX trades at a price-to-book (P/B) ratio of 4.00, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MLTX pay dividends?

MLTX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MLTX's dividend yield?

MLTX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MLTX stock a good long-term investment?

MLTX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MLTX's revenue growth rate?

Revenue growth data for MLTX is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MLTX are available on our dashboard with complete income statement analysis.

What are the risks of investing in MLTX?

Key risks for MLTX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MLTX compare to its competitors?

Compare MLTX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MLTX's performance and positioning.

What is MLTX's stock price target for 2026?

Our AI model provides price targets for MLTX based on fundamental analysis: Bull case $21.23 (+30%), Base case $18.78 (+15%), Bear case $14.70 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MLTX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MLTX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MLTX's next earnings report?

MLTX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MLTX - Moonlake Immunotherapeutics

NYSE * Health Care * Biotechnology

$16.33

$-0.43 (-2.57%)

About Moonlake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

MLTX Key Statistics

Market Cap

$1.16B

P/B Ratio

4.00

EPS

$-3.33

Employees

100

How MLTX Compares to Peers

MLTX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MLTX(This stock)	$1.16B	N/A	0%	0.0%	-
AMGNAmgen Inc	$178.24B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.03B	19.2	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.35B	31.2	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.77B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.26B	15.1	0%	0.2%	vs BIIB

Moonlake Immunotherapeutics Company Information

Headquarters: Massachusetts; U.S.A
Website: www.moonlaketx.com
Sector: Health Care
Industry: Biotechnology

Data Updated: January 21, 2026 at 5:40 AM EST

Ready to invest in MLTX?

Commission-free trading available. Affiliate links.

MLTX Lician Score

5% confidence

4.0/10

Neutral

MLTX has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates MLTXacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

MLTX Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for MLTX

Dashboard

Enter a ticker to analyze